Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.
Exelon Corp.
EXCUtilitiesGenerated Aug 19, 2026, 11:15 PM UTC
EXC (Exelon Corp.) analytical snapshot. Revenue grew +5.3% YoY to $24.26B. 5-year revenue CAGR -7.8%; 10y CAGR -2.8%. Net margin at 11.41% (expanding ▲). Market cap $46.35B at $45.30 per share. Trailing P/E 26.03, P/S 1.91, P/B 1.58. EV/Operating income ≈ 18.47 (EV $95.07B). Risk: Elevated. Macro: Risk-on · Supportive. Composite analytical score -14 (data confidence 82%). Descriptive analytics from public filings — not investment advice.
Free SEC analysis
— computed from SEC filings, free to readFilings & Ownership
Latest annual report (10-K) filed Feb 12, 2026. Latest quarterly report (10-Q) filed Jul 30, 2026. 18 recent 8-K material-event filings in the index.
- Latest annual report (10-K) filed Feb 12, 2026.
- Latest quarterly report (10-Q) filed Jul 30, 2026.
- 18 recent 8-K material-event filings in the index.
- Recent insider Form 4s: 0 buy vs 0 sell transactions.
- ~10,000+ recent 13F-HR filings reference Exelon Corp.; broad institutional reporting.
- Recent filers include SPHINX TRADING, LP, SPHINX TRADING, LP, Crow Point Partners, LLC.
- 20 recent 13G passive institutional ownership notices.
| Filer | Form | Filed |
|---|---|---|
| SPHINX TRADING, LP | 13F-HR | Feb 6, 2015 |
| SPHINX TRADING, LP | 13F-HR | Feb 9, 2015 |
| Crow Point Partners, LLC | 13F-HR | Feb 10, 2009 |
| Allen Investment Management LLC | 13F-HR | Feb 14, 2007 |
| MARK MORRIS ET AL | 13F-HR | Aug 13, 2008 |
| Date | Form | Description |
|---|---|---|
| Jul 30, 2026 | 8-K | 8-K |
| May 6, 2026 | 8-K | 8-K |
| Apr 30, 2026 | 8-K | 8-K |
| Apr 16, 2026 | 8-K | 8-K |
| Feb 20, 2026 | 8-K | 8-K |
| Feb 12, 2026 | 8-K | 8-K |
| Dec 4, 2025 | 8-K | 8-K |
| Nov 26, 2025 | 8-K | 8-K |
SEC Filing Deep-Analysis
2 risk signal(s), 1 positive signal(s), 1 watch item(s) detected from XBRL filing diff analysis. Revenue grew +5.3% but receivables grew +20.4% — the receivables-to-revenue gap suggests growth may be partially driven by extended credit terms rather than genuine demand. If DSO continues to rise, a revenue reversal or bad-debt charge could follow.
- Receivables outpacing revenue: Accounts receivable grew +20.4% YoY vs revenue growth of +5.3%. The +15.1% spread suggests extended credit terms, channel stuffing risk, or collection deterioration. Investigate the allowance for doubtful accounts and DSO trend.
- Restatement of financial statements: The term "restatement of" "previously issued" appears in 2 recent filing(s) (vs 3 in the prior period). This risk language is ongoing.
- Operating cash flow exceeds net income: OCF is 2.26x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.
- NEW: Off-balance sheet arrangements: Off-balance sheet arrangements appears in recent filings but not in the prior 24-month period. Monitor for materiality.
- Endogenous analysis: Revenue grew +5.3% but receivables grew +20.4% — the receivables-to-revenue gap suggests growth may be partially driven by extended credit terms rather than genuine demand. If DSO continues to rise, a revenue reversal or bad-debt charge could follow.
- 2 new XBRL disclosure(s) in latest filing — expanding reporting scope.
- 20 disclosure(s) dropped from prior year — reduced reporting granularity.
- 1 new risk-language term(s) detected in filing text: Off-balance sheet arrangements.
- Ongoing high-severity risk language: Restatement of financial statements.
| Metric | Prior year | Latest year | Change | % Change |
|---|---|---|---|---|
| Revenue | $23.03B | $24.26B | $1.23B | +5.3% |
| Operating income | $4.32B | $5.15B | $829.0M | +19.2% |
| Net income | $2.46B | $2.77B | $308.0M | +12.5% |
| Operating cash flow | $5.57B | $6.25B | $685.0M | +12.3% |
| Capex | $7.10B | $8.53B | $1.43B | +20.2% |
| Total assets | $107.78B | $116.57B | $8.79B | +8.2% |
| Total liabilities | $80.86B | $87.77B | $6.91B | +8.5% |
| Long-term debt | $44.67B | $49.43B | $4.76B | +10.7% |
| Cash & equivalents | $357.0M | $626.0M | $269.0M | +75.4% |
| Stockholders equity | $26.92B | $28.80B | $1.88B | +7.0% |
| Accounts receivable | $2.74B | $3.30B | $559.0M | +20.4% |
| Interest expense | $1.59B | $1.61B | $19.0M | +1.2% |
| Type | Concepts |
|---|---|
| Added | EffectiveIncomeTaxRateReconciliationNondeductibleExpense, IncomeTaxReconciliationNondeductibleExpense |
| Removed | AccumulatedDeferredInvestmentTaxCredit, CurrentFederalTaxExpenseBenefit, CurrentStateAndLocalTaxExpenseBenefit, DebtInstrumentCarryingAmount, DebtInstrumentFairValue, DebtInstrumentUnamortizedDiscountPremiumNet, DeferredFederalIncomeTaxExpenseBenefit, DeferredIncomeTaxLiabilities, DeferredStateAndLocalIncomeTaxExpenseBenefit, DeferredTaxAssetsDerivativeInstruments |
| Term | Severity | Recent | Prior | Status |
|---|---|---|---|---|
| Restatement of financial statements | high | 2 | 3 | Ongoing |
| Impairment charge | medium | 5 | 3 | Ongoing |
| Restructuring | medium | 5 | 2 | Ongoing |
| Off-balance sheet arrangements | medium | 5 | 0 | NEW |
| Related party transactions | low | 5 | 8 | Ongoing |
Fundamentals
Revenue grew +5.3% YoY to $24.26B. 5-year revenue CAGR -7.8%; 10y CAGR -2.8%. Net margin at 11.41% (expanding ▲).
- Revenue grew +5.3% YoY to $24.26B.
- 5-year revenue CAGR -7.8%; 10y CAGR -2.8%.
- Net margin at 11.41% (expanding ▲).
- Return on equity 9.61%, ROA 2.37%, ROIC 6.58%.
- Gross margin 0.00%, operating margin 21.22%.
- Free cash flow margin -9.38% (-$2.27B).
- Net income up ▲ +12.5% YoY.
- Debt/equity 1.69, current ratio 0.94, net debt $48.72B.
- Asset turnover 0.21 — capital efficiency.
| FY | Revenue | Rev YoY | Gross% | Op% | Net% | FCF | ROE% |
|---|---|---|---|---|---|---|---|
| 2024 | $23.03B | +6.0% | 0.00 | 18.76 | 10.68 | -$1.53B | 9.14 |
| 2025 | $24.26B | +5.3% | 0.00 | 21.22 | 11.41 | -$2.27B | 9.61 |
| Quarter end | Revenue | YoY | QoQ | Net margin |
|---|---|---|---|---|
| Jun 30, 2024 | $5.36B | +11.3% | — | — |
| Sep 30, 2024 | $6.15B | +2.9% | +14.8% | — |
| Mar 31, 2025 | $6.71B | +11.1% | +9.1% | — |
| Jun 30, 2025 | $5.43B | +1.2% | -19.2% | — |
| Sep 30, 2025 | $6.71B | +9.0% | +23.5% | — |
| Mar 31, 2026 | $7.24B | +7.9% | +8.0% | — |
Pro analysis — preview
— score, signals & key metrics shown; full reasoning lockedValuation
Market cap $46.35B at $45.30 per share. Trailing P/E 26.03, P/S 1.91, P/B 1.58. EV/Operating income ≈ 18.47 (EV $95.07B).
- Market cap $46.35B at $45.30 per share.
Price & Technicals
Price $45.30 — downtrend (below 200-DMA); 1-month momentum negative. RSI(14) 46.87.
- Price $45.30 — downtrend (below 200-DMA); 1-month momentum negative.
Macro & Rates
Risk-on · Supportive. Real GDP growth 1.50% (quarterly, as of Apr 1, 2026). CPI inflation +3.3% YoY. Fed funds rate 3.63%, 10Y Treasury 4.71%.
- Market regime: Risk-on · Supportive.
Risk Scorecard
Composite risk Elevated. Leverage debt/equity 1.69 (moderate). Liquidity current ratio 0.94 (stretched).
- Composite risk: Elevated.
See the full picture behind every stock
Unlock the complete 10-year fundamentals, DCF & Graham intrinsic value, 13F/13D ownership flow, risk scorecard, multi-analyst bull/bear debate — plus watchlist alerts and your research workspace. Start with a 14-day Pro trial.
3 sections free · 4 Pro previews · composite -14
Macro exposure
Rate-sensitive · High sensitivityMacro regime: Risk-on · Supportive. Exelon Corp. is a rate-sensitive name (high macro sensitivity) — a supportive backdrop, though defensives lag risk-on tapes.
Analytical read
deterministic previewMarket regime: Risk-on · Supportive..
Peer comparison
Rate-sensitive groupHow EXC stacks up against tracked peers with similar macro sensitivity — by analytical score and macro exposure.
| Company | Score | Macro |
|---|---|---|
| Allstate Corp. ALL | 30 | Neutral |
| Visa Inc. V | 24 | Neutral |
| CME Group Inc. CME | 23 | Neutral |
| Capital One Financial COF | 21 | Neutral |
| Charles Schwab Corp. SCHW | 19 | Neutral |
| American Express Co. AXP | 16 | Neutral |
| Simon Property Group SPG | 15 | Neutral |
| Digital Realty Trust DLR | 13 | Neutral |
| Mastercard Inc. MA | 11 | Neutral |
| U.S. Bancorp USB | 10 | Neutral |
| Travelers Cos. TRV | 10 | Neutral |
| Chubb Ltd. CB | 7 | Neutral |
| MetLife Inc. MET | 7 | Neutral |
| JPMorgan Chase & Co. JPM | 7 | Neutral |
| Welltower Inc. WELL | 6 | Neutral |
| Dominion Energy D | 4 | Neutral |
| Bank of America Corp. BAC | 3 | Neutral |
| Moody's Corp. MCO | 2 | Neutral |
| PNC Financial Services PNC | 2 | Neutral |
| Wells Fargo & Co. WFC | 1 | Neutral |
| BlackRock Inc. BLK | 1 | Neutral |
| American Tower Corp. AMT | 0 | Neutral |
| American Electric Power AEP | 0 | Neutral |
| Bank of New York Mellon BK | 0 | Neutral |
| Marsh & McLennan MMC | 0 | Neutral |
| Truist Financial TFC | -1 | Neutral |
| American Water Works AWK | -2 | Neutral |
| Equinix Inc. EQIX | -4 | Neutral |
| Goldman Sachs Group GS | -4 | Neutral |
| Prologis Inc. PLD | -5 | Neutral |
| Xcel Energy XEL | -5 | Neutral |
| Public Storage PSA | -5 | Neutral |
| Citigroup Inc. C | -5 | Neutral |
| Realty Income Corp. O | -6 | Neutral |
| Equity Residential EQR | -10 | Neutral |
| NextEra Energy NEE | -13 | Neutral |
| Duke Energy Corp. DUK | -14 | Neutral |
| Southern Company SO | -14 | Neutral |
| Exelon Corp. EXC● you | -14 | Neutral |
| Morgan Stanley MS | -14 | Neutral |
| S&P Global SPGI | -19 | Neutral |
| Crown Castle Inc. CCI | -21 | Neutral |
| American International Group AIG | -23 | Neutral |